These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9257085)

  • 1. Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.
    Foster RH; Wilde MI; Markham A
    Drugs; 1997 Aug; 54(2):312-30. PubMed ID: 9257085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
    Varriale P; Sedighi A
    Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibutilide: a new class III antiarrhythmic agent.
    Granberry MC
    Am J Health Syst Pharm; 1998 Feb; 55(3):255-60. PubMed ID: 9492255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
    Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2005 May; 14(5):655-69. PubMed ID: 15926871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibutilide: a new class III antiarrhythmic agent.
    Cropp JS; Antal EG; Talbert RL
    Pharmacotherapy; 1997; 17(1):1-9. PubMed ID: 9017761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiology and pharmacology of ibutilide.
    Naccarelli GV; Lee KS; Gibson JK; VanderLugt J
    Am J Cardiol; 1996 Oct; 78(8A):12-6. PubMed ID: 8903270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
    Stambler BS; Wood MA; Ellenbogen KA
    Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.